Working capital increased 24.3%
Working capital changed +24.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital changed +24.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed +131.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Trade receivables changed +26.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed -570 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / revenue changed -72350 basis points from the comparable as-filed period.
Operating cash-flow margin changed +3000 basis points from the comparable as-filed period.
Research & development changed +26.9% from the comparable as-filed period.
SBC / revenue changed -197 basis points from the comparable as-filed period.
Operating cash flow / net income changed -54.6% from the comparable as-filed period.
Total assets changed +10.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross debt changed +8.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Reported total debt changed +8.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -15.7% from the comparable as-filed period.
Debt / assets changed -124 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital / assets changed +32 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed +1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
R&D / revenue changed -24 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.